ARCHIVES

Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB.

This article is from The Cancer Letter archive.

Vol. 32 No. 23 | June 16, 2006

Download PDF Visit The Full Archive

Related Articles

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

NCI Official Says Public Health Issue As Important As Data In Mammography

April 2, 1993

NCI CTEP Approved Trials For the Month of September

September 27, 2013

“Tone” Of Statement Lacks Balance, Klausner Says

January 31, 1997

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000